Medicus Pharma Ltd. SEC filings MDCX
Medicus Pharma Ltd. has 343 filings in SEC EDGAR's recent list, going back to Oct 13, 2023. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 16, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 14, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 5, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 5, 2026 | — |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 3/A | Ownership document | Aug 6, 2025 | Jun 30, 2025 |
| 3 | Initial insider ownership | Jul 31, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 3 | Initial insider ownership | Jul 3, 2025 | Jun 30, 2025 |
| 3/A | Ownership document | May 21, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 3/A | Ownership document | Apr 3, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| 3/A | Ownership document | Feb 10, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| 3/A | Ownership document | Jan 23, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 13, 2025 | — |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
| 3 | Initial insider ownership | Dec 31, 2024 | Dec 31, 2024 |
Showing 96 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDCX (Nasdaq), MDCXW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- W. Conshohocken, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1997296
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.